Basophils, recruited from the blood to tissues, have been implicated by their presence in diverse allergic disorders including bronchial asthma, allergic rhinitis, and cutaneous contact hypersensitivity. We hypothesized that like other leukocytes involved in inflammatory responses, basophils would express members of the Leukocyte Immunogloblin-like Receptor (LIR) family of immunoregulatory molecules on their cell surface. We identified LIR7, an activating member coupled to the common Fc receptor gamma chain, and LIR3, an inhibitory member containing cytoplasmic immunoreceptor tyrosine-based inhibitory motifs on these cells from human peripheral blood. Crosslinking of LIR7 resulted in the concentration-dependent net release of histamine (29.8±10.8%) and cysteinyl leukotrienes (cysLT) (31.4±8.7 ng/10 6 basophils) that were maximal at 30 minutes, and of Interleukin (IL) 4 (410.2± 61.6 pg/10 6 basophils) that was maximal at 4 hours and comparable to the response initiated by cross-linking of the high affinity receptor for IgE (Fc RI). Co-ligation of LIR3 to LIR7 or to Fc RI by means of a second monoclonal antibody significantly inhibited net histamine release, cysLT production, and IL-4 generation. That LIR3 is profoundly counter-regulatory for both adaptive and innate receptors suggests a broad role in containment of the inflammatory response.
Introduction
Because they resemble mast cells in their panel of mediators and cell surface expression of Fc RI, peripheral blood basophils have in the past often been studied as mast cell surrogates due to the relative ease with which they can be isolated. However, basophils differ importantly from mast cells in their developmental pathway and limited supply of effector molecules. Developmentally, basophils originate and mature in the bone marrow, circulating as terminally differentiated cells, while mast cells circulate as precursors and complete their development after transendothelial migration to specific tissues [1] [2] [3] . Indeed, basophils bear a closer developmental relationship to eosinophils than to mast cells 4, 5 . A case report documents the absence of both eosinophils and basophils in a single patient 6 , possibly secondary to destruction or dysfunction of a shared progenitor cell. Infection of Ws/Ws rats, that are deficient in mast cells due to a mutation in c-kit, with the parasite Nippostrongylus brasiliensis led to a greater than 50-fold increase in peripheral blood basophils, equal to that observed in wild type rats . That basophils can provide IL-4 has led to the suggestion that these cells may reinforce TH2 cell polarization [10] [11] [12] . Basophils are also able to express CD40 ligand on their surface and have been shown to independently support IgE production by B cells in vitro 10 .
For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From Basophils have been implicated in a number of human diseases including bronchial asthma, allergic rhinitis, and cutaneous contact hypersensitivity. Increased numbers of basophils, as detected by immunohistochemistry employing mAb 2D7, are found in bronchial biopsy specimens from patients with fatal asthma 13 . Compared to non-asthmatic controls, patients with allergic asthma had more basophils in airway biopsy tissue prior to inhaled allergen challenge, and there was a significant increase in tissue basophils 24 hours after challenge 14 . In patients with allergic rhinitis, allergen challenge in the nose released histamine, cysteinyl leukotrienes, and PGD 2 in the immediate phase response, and histamine and cysteinyl leukotrienes without PGD 2 in the late phase response (LPR) 15 . That mast cells but not basophils generate PGD 2 suggests that basophils are the likely source of histamine and cysteinyl leukotrienes in the LPR. This is supported by the 12-fold rise in alcian blue positive cells in nasal lavage fluids during the LPR, ~70% of which are basophils by morphologic criteria 16 .
Histologic studies of skin lesions from patients with allergic contact dermatitis to urushiol/oleoresin, responsible for poison ivy reactions, which is not IgE-dependent, demonstrate substantial infiltration of basophils, basophil degranulation, and evidence of increased vascular permeability [17] [18] [19] . Serial biopsies of one patient showed that basophils enter the dermis after lymphocytes but prior to the arrival of eosinophils, and account for up to one in six of the inflammatory cells. Control biopsies from the same individual after antigen-independent skin trauma with liquid nitrogen did not evoke tissue basophilia. Thus, basophils accumulate and are activated in both IgE-mediated and T cell-dependent allergic diseases.
For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From Given their relatively low concentrations of preformed effector molecules, their ability to release immunomodulatory cytokines, their expression of co-stimulatory molecules, and their prominence in different classes of allergic reactions, we decided to determine the presence and function on basophils of a novel set of receptors with both activating and inhibitory members. The LIR's 20, 21 , also called Immunoglobulin Like Transcripts (ILT's) [22] [23] [24] and recently given the CD designation CD85a-h 25 , are a set of Ig superfamily proteins expressed by leukocytes. The LIRs are encoded on two loci separated by a region of ~200 kb within the leukocyte receptor complex on chromosome 19q13.4 26, 27 . Genes encoding LIR3, ILT8, LIR8, LIR2, LIR4, ILT11, and ILT7 lie in the centromeric cluster and genes encoding LIR7, LIR6, LIR1, LIR5, and the pseudogenes ILT9 and ILT10 lie in the telomeric cluster, immediately adjacent to the genes encoding the killer cell Ig-like receptors (KIRs) 28 . cycloheximide, and protein A sepharose were from Sigma, St. Louis, MO. PIPES buffer was 25mM PIPES, 110mM NaCl, 5mM KCl, pH 7.4. Percoll (Pharmacia, Uppsala, Sweden) was equilibrated 9:1 (vol:vol) with 10X PIPES buffer, and then diluted with PIPES buffer to a specific gravity of 1.0863. PAG buffer was PIPES buffer with 0.003% HSA, and 0.1% dextrose (Fisher Scientific, Suwanee, GA). PAB buffer was 1X PBS with 0.05% NaN 3 and 1% BSA. RPMI medium was RPMI 1640 (Gibco, Invitrogen Corp., Carlsbad, CA; or Cellgro, Mediatech, Herndon, VA), 10% heat inactivated fetal bovine serum (Sigma), 100 units per ml penicillin, 100 µg per ml streptomycin, nonessential amino acids (Cellgro, Mediatech, Herndon, VA), and 25mM HEPES.
Recombinant human IL-3 was from Pierce Endogen (Woburn, MA), or from R and D
Systems (Minneapolis, MN)
Monoclonal mouse IgG 1 antibodies (mAbs) against LIRs 1, 2, 3, 5, 6, and 8 were previously described 20, 31 and are designated m401, m421, m431, m451,m467, and m481, respectively. We used two murine 2 anti-mouse IgG 1 (F(ab') 2 -specific) with minimal cross-reactivity to human, rat, and bovine serum; normal goat serum; goat F(Ab') 2 anti-mouse IgG (Heavy and Light chain-specific, minimal cross-reactivity to human, rat, and horse serum); and rabbit anti-goat IgG (F(ab') 2 -specific) were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA).
Isolation and LIR epitope expression of human basophils
Basophils, but not other granulocytes, co-sediment with human peripheral blood mononuclear cells (PBMC) in density gradients. Therefore, venous blood was anticoagulated with EDTA, diluted with 0.9% NaCl, layered over Percoll, and centrifuged at 300xg to separate the PBMC population. Highly purified basophils were isolated from PBMC by negative selection with antibody-coated magnetic beads (Miltenyi Biotech, Inc., Auburn, CA). Purity of basophils was assessed by Alcian blue or Toluidine blue staining and was 92.3 ± 2.5% (n=12).
LIR expression on purified human basophils was determined by flow cytometry using mAbs (10 µg/ml) to individual LIRs and FITC-conjugated goat F(ab') 2 anti-mouse IgG 1 [F(ab') 2 -specific] as described for human eosinophils in an ice slurry for 1 minute, followed by centrifugation at 200xg at 4°C for 10 minutes.
The supernatants were stored at -20°C until they were assayed for histamine and LTC 4 .
To determine the requirement for IL-3 priming, a parallel sample of cells was processed and stimulated as described, except that IL-3 was omitted from each step. Initial experiments were performed with m471 at 1µg/ml. Subsequent experiments performed with m473 at 0.1µg/ml provided similar release of histamine and LTC 4 .
For experiments in which release of IL-4 was measured, purified basophils were blocked and primed under the same conditions as above except that RPMI medium was used instead of PAG buffer, and cells were stimulated at a 2-fold greater density of 
Statistical analysis
Data are expressed as means ± SE. Statistical analyses of dose-response curves and kinetics were done by analysis of variance. Statistical comparisons between two sets of data were done by paired t tests. Differences were considered significant for p<0.05.
For
Results

Cytofluorgraphic anaylsis of LIR expression by human peripheral blood basophils
As a reference for an analysis of LIR expression on the basophil, a parallel study was conducted with monocytes (data not shown) which express each LIR for which there is a currently available mAb 20, 33, 37 . Basophils from 7 of 7 donors invariably expressed a modest monophasic peak for LIR3 and LIR7, respectively, as illustrated for one donor (Fig 1) whose basophils also expressed minimal LIR2. Basophils from less than half the donor group of seven individuals also expressed minimal LIR1 or LIR2. Mean fluorescence intensities for staining with control IgG 1 , and mAbs to LIR-3, LIR-7, and Fc RI were 7.7 ± 1.2, 15.4 ± 1.4, 12.1 ± 1.5, and 19.4 ± 1.1, respectively (n=7).
Cross-linking of LIR-7 on basophils in PBMC or purified basophils
Because basophils are the only leukocytes in the PBMC fraction that contain histamine, the activation through LIR7 to elicit histamine release was examined using this mixed cell preparation. Basophils comprised 2.66% ± 0.37% of PBMC in these experiments.
Cross-linking of LIR7 elicited histamine release in a concentration-dependent manner To address the contribution of contaminating PBMC to basophil histamine and leukotriene release, high purity and low purity basophils from the same donor were stimulated through LIR-7. For basophils of 98% and 5% purity the net release of histamine was 14.5% and 19.0%, respectively, and cys-LT release was 5.7 and 4.6 ng/10 6 basophils, repectively. Therefore, basophils were the major if not exclusive source of histamine and CysLTs in the PBMC population stimulated by LIR7 crosslinking, and mediator release was due to direct stimulation of basophils through LIR-7
and not due to an indirect effect of cross-linking LIR-7 expressed on PBMCs.
Because LIR7 was expressed by mononuclear cells in the PBMC population, IL-4 release in response to stimulation through LIR7 was analyzed using high purity basophil preparations. In concentration response experiments, the onset of IL-4 secretion over the background was observed with 0.01µg/ml anti-LIR7 and was maximal at 0.1-0.3µg/ml (p=0.004 versus IgG). The maximal net release of IL-4 from basophils in response to stimulation through LIR7 and Fc RI was 410.2 ± 61.6 pg/10 6 basophils (n = 3) and 246.0 ± 51.3 pg/10 6 basophils (n = 3), respectively. Kinetic experiments showed a plateau at 4 hours (n=3, Figure 4B ). No detectable release of IL-4 was observed when LIR-7 was cross-linked on mixed PBMC (~4% basophils) indicating that contaminating PBMC are not the source of IL-4 when LIR-7 is cross-linked.
IL-3 effects
Release of mediators from basophils in response to a number of different stimuli requires pretreatment of the cells with IL-3
38
. We used IL-3 pretreatment routinely by
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In 5 separate experiments, histamine release from unstimulated basophils in PBMC was 12 ± 3% without IL-3 pretreatment, and the response to LIR7 stimulation provided a net gain of 32 ± 7% (p < 0.01) ( Figure 5A ). IL-3 pretreatment alone increased histamine release to 25 ± 9% and the net gain with cross-linking of LIR7 was 31 ± 7% and therefore no more than additive to IL-3. For cysLT generation ( Figure 5B For as previously reported 11, 12 . Basophil survival at 4 hours under all conditions was greater than 92% and thus the fall off in IL-4 release after cycloheximide pretreatment is not attributable to cytotoxicity. Furthermore, at the earlier time point of 45 minutes cycloheximide treatment did not attenuate histamine release in response to crosslinking of LIR-7; 50.2 ± 15.4% and 54.6 ± 12.6% in the absence and presence of 10µM cycloheximide, respectively (n = 3).
Effect of co-ligation of LIR3 to the activating receptors LIR7 and Fc RI, respectively
The ability of the ITIM-containing LIR3 to attenuate mediator release elicited by crosslinking of LIR7 or Fc RI was examined for each basophil-derived mediator. Because the window for the LIR3 counter-regulatory effect rests between baseline and the net increment over baseline, the percent inhibition must be calculated from those parameters. Data is presented for basophils stimulated in the presence of IL-3. For histamine ( Figure 7A ) there was no difference in baseline release when mAb to LIR3 was substituted for non-specific IgG. The net increment with cross-linking of 0.1 µg/ml anti-LIR7 was 27 ± 11% of the total cellular histamine, and this was suppressed in a concentration-dependent fashion by co-ligation to LIR3 (p=0.005, Figure 7A ). The dose response was similar when the activating ligand was 0.1 µg/ml anti-Fc RI (p=0.017, Figure 7B ). For the six experiments performed with IL-3, the maximal inhibition with 10.0 µg/ml anti-LIR3 was 65±10% and 47±14% for LIR7-and Fc RI-stimulated histamine release, respectively. Control non-specific IgG or anti-CD154 in place of anti-LIR3 were not inhibitory at concentrations up to 10 µg/ml. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From 10.0 µg/ml anti-LIR3 was 76 ± 9% (n=4) for LIR7 and 58 ± 6% (n=5) for Fc RI. Control non-specific IgG and anti-CD154 in place of anti-LIR3 were not inhibitory at concentrations up to 10 µg/ml.
Because of the difficulty in obtaining large numbers of purified basophils, experiments in which LIR3 was co-ligated to either LIR7 or Fc RI to inhibit release of IL-4 were performed using only the highest concentration of anti-LIR3 (10.0 µg/ml). To examine the function of LIRs expressed on basophils, we cross-linked LIR7 using specific murine monoclonal antibodies followed by a goat anti-mouse IgG. Crosslinking of LIR7 elicited release of mediators from three compartments: preformed histamine from secretory granules, de novo synthesis of LTC 4 from arachidonic acid, and IL-4 release (Figures 2 to 4) . The time course of IL-4 generation and its inhibition by cycloheximide ( Figure 6 ) indicate that IL-4 was generated de novo by gene induction.
The only other "complete" stimulus identified thus far, releasing all three compartments of mediators is activation through the high affinity IgE receptor 11, 38, [40] [41] [42] [43] [44] [45] . A 21 kDa histamine releasing factor, whose action appears to be IgE-dependent, is also a complete stimulus for basophil mediator release, but it is active only on basophils from ~50% of individuals [46] [47] [48] . Our study therefore not only identifies LIR7 as a novel signaling receptor on human basophils, but also identifies activation through LIR7 as the For 
